Cited by 1,007Schizophrenia research and treatmentPsychometric Methodologies and TestingPsychological Testing and Assessment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, Stanley R., Opler, Lewis A., Lindenmayer, Jean-Pierre·1988·Psychiatry Research

DOI 10.1016/0165-1781(88)90038-8

Open this paper in CoChat — free account

Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings.

Integrity signals

Registry

Crossref · 10.1016/0165-1781(88)90038-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Positive and negative symptoms in schizophrenia
Rosen, W. G., Mohs, R. C., Johns, C. A., Small, N. S., Kendler, K. S., Horvath, T., & Davis, K. L. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90075-1 · Cited by 238

Show all 28 references

Research works printed but not linked: 1

Kay, 1981, Arousal in schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11, 35

Sorted by citations

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Risperidone in the treatment of schizophrenia
Marder, S. R., & Meibach, R. C. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,194
The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation
Kay, S. R., Opler, L. A., & Lindenmayer, J.-P. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291514 · Cited by 1,016
Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial
Morrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., Green, J., Parker, S., & Bentall, R. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.4.291 · Cited by 740
The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard, J. J., & Cohen, A. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj013 · Cited by 649
Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol
Peuskens, J. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.6.712 · Cited by 551
Transcranial Magnetic Stimulation of Left Temporoparietal Cortex and Medication-Resistant Auditory Hallucinations
Hoffman, R. E., Hawkins, K. A., Gueorguieva, R. V., Boutros, N. N., Rachid, F., Carroll, K. M., & Krystal, J. H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.49 · Cited by 520
Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia
Peralta, V., & Cuesta, M. J. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90093-0 · Cited by 583
Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics
Lindenmayer, J., Czobor, P., Volavka, J., Citrome, L., Sheitman, B., McEvoy, J. P., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.290 · Cited by 465
Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder
Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J., Citrome, L., McEvoy, J. P., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.255 · Cited by 408
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis
Emsley, R. A., Rabinowitz, J., & Torreman, M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00302-x · Cited by 387
De Scale for the Assessment of Negative Symptoms
van Dusseldorp, L., & de Niet, G. (2006) · Psychopraxis · doi:10.1007/bf03072275 · Cited by 334
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study
Claus, A., Bollen, J., Cuyper, H. D., Eneman, M., Malfroid, M., Peuskens, J., & Heylen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01473.x · Cited by 295
Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study
Bondolfi, G., Dufour, H., Patris, M., May, J. P., Billeter, U., Eap, C. B., & Baumann, P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.4.499 · Cited by 283
A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures
Brazier, J. E., Connell, J., Papaioannou, D. E., Mukuria, C., Mulhern, B. J., Peasgood, T., Jones, M. L., Paisley, S., O’Cathain, A., Barkham, M., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18340 · Cited by 288
Clozapine alone versus clozapine and risperidone with refractory schizophrenia
Honer, W. G., Thornton, A. E., Chen, E. Y. H., Chan, R. C. K., Wong, J. O. Y., Bergmann, A., Falkai, P., Pomarol-Clotet, E., McKenna, P. J., Stip, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053222 · Cited by 277
Dissociation mediates the relationship between childhood trauma and hallucination-proneness
Varese, F., Barkus, E., & Bentall, R. P. (2011) · Psychological Medicine · doi:10.1017/s0033291711001826 · Cited by 311
Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample
Hoffman, R. E., Gueorguieva, R., Hawkins, K. A., Varanko, M., Boutros, N. N., Wu, Y.-T., Carroll, K., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.041 · Cited by 272
Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.
Margolese, H., Malchy, L., Negrete, J., Tempier, R., & Gill, K. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00523-6 · Cited by 277
Association of Cerebral Deficits With Clinical Symptoms in Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry and Resting State Functional Connectivity Study
Lui, S., Deng, W., Huang, X., Jiang, L., Ma, X., Chen, H., Zhang, T., Li, X., Li, D., Zou, L., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020183 · Cited by 258
Fluctuations in self-esteem and paranoia in the context of daily life.
Thewissen, V., Bentall, R. P., Lecomte, T., van Os, J., & Myin‐Germeys, I. (2008) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.117.1.143 · Cited by 272
Dimensions of Outcome with Clozapine
Meltzer, H. Y. (1992) · The British Journal of Psychiatry · doi:10.1192/s000712500029692x · Cited by 251
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
Morrison, A. P., Turkington, D., Pyle, M., Spencer, H. M., Brabban, A., Dunn, G., Christodoulides, T., Dudley, R. E. J., Chapman, N., Callcott, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62246-1 · Cited by 265
Social anxiety and the shame of psychosis: A study in first episode psychosis
Birchwood, M. J., Trower, P., Brunet, K., Gilbert, P., Iqbal, Z., & Jackson, C. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.07.011 · Cited by 272
Dissociation, trauma, and the role of lived experience: Toward a new conceptualization of voice hearing.
Longden, E., Madill, A., & Waterman, M. G. (2012) · Psychological Bulletin · doi:10.1037/a0025995 · Cited by 248
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Cassidy, C., Zucca, F. A., Girgis, R. R., Baker, S. C., Weinstein, J. J., Sharp, M. E., Bellei, C., Valmadre, A., Vanegas‐Arroyave, N., Kegeles, L. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807983116 · Cited by 245
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial
Scheewe, T. W., Backx, F. J. G., Takken, T., Jörg, F., van Strater, A. C. P., Kroes, A. G., Kahn, R. S., & Cahn, W. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12029 · Cited by 246
Emotions, self-esteem, and paranoid episodes: An experience sampling study
Thewissen, V., Bentall, R. P., Oorschot, M., à Campo, J., van Lierop, T., van Os, J., & Myin‐Germeys, I. (2011) · British Journal of Clinical Psychology · doi:10.1348/014466510x508677 · Cited by 236
EPA guidance on assessment of negative symptoms in schizophrenia
Galderisi, S., Mucci, A., Dollfus, S., Nordentoft, M., Falkai, P., Kaiser, S., Giordano, G. M., Vandevelde, A., Nielsen, M. Ø., Glenthøj, L. B., et al. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.11 · Cited by 249
Why Do People With Delusions Fail to Choose More Realistic Explanations for Their Experiences? An Empirical Investigation.
Freeman, D., Garety, P. A., Fowler, D., Kuipers, E., Bebbington, P. E., & Dunn, G. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.671 · Cited by 229
Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia
Speers, A. B., Cabey, K., Soumyanath, A., & Wright, K. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210712151556 · Cited by 255
Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy
Markowitz, J. S., Brown, C. S., & Moore, T. R. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17215 · Cited by 208
EFFECTS OF EXERCISE ON MENTAL AND PHYSICAL HEALTH PARAMETERS OF PERSONS WITH SCHIZOPHRENIA
Beebe, L. H., Tian, L., Morris, N., Goodwin, A., Allen, S. S., & Kuldau, J. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840590959551 · Cited by 259
Are the available apathy measures reliable and valid? A review of the psychometric evidence
Clarke, D. E., Ko, J. Y., Kuhl, E. A., van Reekum, R., Salvador, R., & Marin, R. S. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.01.012 · Cited by 199
Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode
Caspi, A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00056-2 · Cited by 201
Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects
Berlin, I., Givry-Steiner, L., Lecrubier, Y., & Puech, A. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)80048-5 · Cited by 178
A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia
GOFF, D. C., Lamberti, J. S., Leon, A. C., Green, M. F., Miller, A. L., Patel, J. K., Manschreck, T. C., Freudenreich, O., & Johnson, S. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301444 · Cited by 181
Machine-learning-based diagnosis of schizophrenia using combined sensor-level and source-level EEG features
Shim, M., Hwang, H., Kim, D.-W., Lee, S., & Im, C. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.007 · Cited by 181
Research Units on Pediatric Psychopharmacology (Rupp) Autism Network
McDougle, C. J., Scahill, L. D., McCracken, J. T., Aman, M. G., Tierney, E., Arnold, L. E., Freeman, B. J., Martin, A., McGough, J. J., Cronin, P., et al. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30142-1 · Cited by 179
Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations
Høyberg, O. J., Fensbo, C., Lingjærde, O. C., Sloth-Nielsen, M., Salvesen, I., & Remvig, J. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03480.x · Cited by 176
The communicative impairment as a core feature of schizophrenia: Frequency of pragmatic deficit, cognitive substrates, and relation with quality of life
Bambini, V., Arcara, G., Bechi, M., Buonocore, M., Cavallaro, R., & Bosia, M. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.08.012 · Cited by 175
Psychometric properties of the Questionnaire about the Process of Recovery (QPR)
Law, H., Neil, S. T., Dunn, G., & Morrison, A. P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.011 · Cited by 172
Word and Tone Working Memory Deficits in Schizophrenia
Wexler, B. E., Stevens, A. A., Bowers, A. A., Sernyak, M. J., & Goldman‐Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1093 · Cited by 173
Negative symptoms in schizophrenia—A review
Mäkinen, J., Miettunen, J., Isohanni, M. K., & Koponen, H. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801959307 · Cited by 173
Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
Chouinard, G., & Chouinard, V.-A. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112883 · Cited by 168
Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders
Perkins, D. O., Lieberman, J. A., Gu, H., Tohen, M. F., McEvoy, J. P., Green, A. I., Zipursky, R. B., Strakowski, S. M., Sharma, T., Kahn, R. S., et al. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.1.18 · Cited by 165
A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis
White, R., Gumley, A., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., & Mitchell, G. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.09.003 · Cited by 161
Case Series: Use of Ziprasidone for Maladaptive Symptoms in Youths With Autism
McDougle, C. J., Kem, D. L., & Posey, D. J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200208000-00010 · Cited by 162
A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations
Lee, S., Kim, W. B., Chung, Y.-C., Jung, K.-H., Bahk, W., Jun, T.-Y., Kim, K., George, M. S., & Chae, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.048 · Cited by 157
Assessment of executive dysfunction during activities of daily living in schizophrenia
Semkovska, M., Bédard, M., Godbout, L., Limoge, F., & Stip, É. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.07.005 · Cited by 160
Anatomical and Functional Brain Abnormalities in Drug-Naive First-Episode Schizophrenia
Ren, W., Lui, S., Deng, W., Li, F. Y., Li, M., Huang, X., Wang, Y., Li, T., Sweeney, J. A., & Gong, Q. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12091148 · Cited by 154
Localization of cerebral functional deficits in treatment-naive, first-episode schizophrenia using resting-state fMRI
Huang, X.-Q., Lui, S., Deng, W., Chan, R. C. K., Wu, Q.-Z., Jiang, L.-J., Zhang, J.-R., Jia, Z.-Y., Li, X.-L., Li, F., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.072 · Cited by 150
Assessing Disability in Older Patients With Schizophrenia: Results From the WHODAS-II
McKibbin, C., Patterson, T. L., & Jeste, D. V. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000130133.32276.83 · Cited by 149
Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls.
Scheewe, T. W., van Haren, N. E. M., Sarkisyan, G., Schnack, H. G., Brouwer, R. M., de Glint, M., Hulshoff Pol, H. E., Backx, F. J. G., Kahn, R. S., & Cahn, W. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.08.008 · Cited by 148
Symptom rating scales and outcome in schizophrenia
Mortimer, A. M. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s7 · Cited by 150
Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives
Laurent, A., Biloa-Tang, M., Bougerol, T., Duly, D., Anchisi, A.-M., Bosson, J., Pellat, J., d’Amato, T., & Jean Dalery, A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00232-7 · Cited by 147
Assessment of physical activity in middle-aged and older adults with schizophrenia
Lindamer, L. A., McKibbin, C. L., Norman, G. J., Jordan, L. S., Harrison, K. A., Abeyesinhe, S., & Patrick, K. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.040 · Cited by 145
The InterSePT scale for suicidal thinking reliability and validity
Lindenmayer, J., Czobor, P., Alphs, L. D., Nathan, A.-M., Anand, R., Islam, Z., & Chou, J. C. Y. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00335-3 · Cited by 144
The Effectiveness of a Patient-Centred Assessment with a Solution-Focused Approach (DIALOG+) for Patients with Psychosis: A Pragmatic Cluster-Randomised Controlled Trial in Community Care
Priebe, S., Kelley, L., Omer, S., Golden, E., Walsh, S., Khanom, H., Kingdon, D., Rutterford, C., McCrone, P., & McCabe, R. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000430991 · Cited by 140
Posttraumatic Stress Disorder Symptoms Related to Psychosis and Acute Involuntary Hospitalization in Schizophrenic and Delusional Patients
MEYER, H., TAIMINEN, T., VUORI, T., ÄIJÄLÄ, A., & HELENIUS, H. (1999) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199906000-00003 · Cited by 131
Positive-negative symptom assessment in schizophrenia: Psychometric issues and scale comparison
Kay, S. R. (1990) · Psychiatric Quarterly · doi:10.1007/bf01064966 · Cited by 134
Dissociative experiences as mediators between childhood trauma and auditory hallucinations
Perona‐Garcelán, S., Carrascoso‐ López, F., García‐Montes, J. M., Ductor‐Recuerda, M. J., López Jiménez, A. M., Vallina‐Fernández, O., Pérez‐Álvarez, M., & Gómez‐Gómez, M. T. (2012) · Journal of Traumatic Stress · doi:10.1002/jts.21693 · Cited by 130
Anxiety and Schizophrenia: The Interaction of Subtypes of Anxiety and Psychotic Symptoms
Huppert, J. D., & Smith, T. E. (2005) · CNS Spectrums · doi:10.1017/s1092852900019714 · Cited by 133
RELATIONSHIP BETWEEN TOBACCO SMOKING AND POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
Patkar, A. A., Gopalakrishnan, R., Lundy, A. C., Leone, F. T., Certa, K., & Weinstein, S. P. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00005 · Cited by 132
Statistical challenges in the evaluation of surrogate endpoints in randomized trials
Molenberghs, G., Buyse, M. E., Geys, H., Renard, D., Burzykowski, T., & Alonso, A. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00236-2 · Cited by 131
The Positive-Negative Distinction in Drug-Free Schizophrenic Patients
Kay, S. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080041005 · Cited by 131
The recovery of metacognitive capacity in schizophrenia across 32 months of individual psychotherapy: A case study
Lysaker, P. H., Buck, K. D., & Ringer, J. M. (2007) · Psychotherapy Research · doi:10.1080/10503300701255932 · Cited by 126
Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects
Depp, C. A., Moore, D. J., Sitzer, D., Palmer, B. W., Eyler, L. T., Roesch, S., Lebowitz, B. D., & Jeste, D. V. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.022 · Cited by 125
Transcranial magnetic stimulation for auditory hallucinations in schizophrenia
McIntosh, A. M., Semple, D. M., Tasker, K., Harrison, L. K., Owens, D. G. C., Johnstone, E. C., & Ebmeier, K. P. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.03.005 · Cited by 125
Measuring cognitive insight in middle-aged and older patients with psychotic disorders
Pedrelli, P., McQuaid, J. R., Granholm, E. L., Patterson, T. L., McClure, F. S., Beck, A. T., & Jeste, D. V. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.019 · Cited by 125
A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain
Henderson, D. C., Copeland, P. M., Daley, T. B., Borba, C. P. C., Cather, C., Nguyen, D. D., Louie, P. M., Evins, A. E., Freudenreich, O., Hayden, D. L., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.954 · Cited by 125
A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS
Norman, R. M. G., MALLA, A. K., Cortese, L., & Diaz, F. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00055-0 · Cited by 121
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders
Schennach-Wolff, R., Jäger, M., Seemüller, F., Obermeier, M., Messer, T., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.032 · Cited by 120
Brief emotion training improves recognition of facial emotions in chronic schizophrenia. A pilot study
Silver, H., Goodman, C., Knoll, G., & Isakov, V. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.06.002 · Cited by 120
Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia
Spina, E., Avenoso, A., Facciolà, G., Salemi, M., Scordo, M. G., Ancione, M., Madia, A. G., & Perucca, E. (2001) · Psychopharmacology · doi:10.1007/s002130000576 · Cited by 120
An excitement subscale of the Positive and Negative Syndrome Scale
Lindenmayer, J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00087-2 · Cited by 120
Altered Cortical Thickness Related to Clinical Severity But Not the Untreated Disease Duration in Schizophrenia
Xiao, Y., Lui, S., Deng, W., Yao, L., Zhang, W., Li, S., Wu, M., Xie, T., Yong He, A., Huang, X., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt177 · Cited by 117
The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study
Ritsner, M. S., Ponizovsky, A. M., Endicott, J., Nechamkin, Y., Rauchverger, B., Silver, H., & Modai, I. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00128-6 · Cited by 114
Neurological signs and the positive-negative dimension in schizophrenia
Merriam, A. E., Kay, S. R., Opler, L. A., Kushner, S. F., & van Praag, H. M. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90573-k · Cited by 114
Asenapine versus olanzapine in acute mania: a double‐blind extension study
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L. D., Macek, T. A., & Panagides, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00749.x · Cited by 113
Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.014 · Cited by 118
Reduced neuronal activity in language-related regions after transcranial magnetic stimulation therapy for auditory verbal hallucinations
Kindler, J., Homan, P., Jann, K., Federspiel, A., Flury, R., Hauf, M., Strik, W., Dierks, T., & Hubl, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.019 · Cited by 112
Schizophrenia and the Motivation for Smoking
Forchuk, C., Norman, R. M. G., MALLA, A. K., Martin, M., McLean, T. S., Cheng, S. K. K., Diaz, K. M., McIntosh, E., Rickwood, A., Vos, S. H., et al. (2009) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2002.tb00656.x · Cited by 110
Obsessive compulsive symptoms in schizophrenia: Frequency and clinical features
Byerly, M., Goodman, W. K., Acholonu, W., Bugno, R., & Rush, A. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.004 · Cited by 110
Comprehension of irony in Schizophrenia
Mitchley, N. J., Barber, J., Gray, J. M., Brooks, D. N., & Livingston, M. G. (1998) · Cognitive Neuropsychiatry · doi:10.1080/135468098396206 · Cited by 110
Neurological soft signs in schizophrenia: Assessment and correlates
Mohr, F., Hubmann, W., Bender, W., Hönicke, S., Wahlheim, C., Cohen, R., Haslacher, C., Schlenker, R., & Werther, P. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190275 · Cited by 109
Neurocognitive Correlates of Positive and Negative Syndromes in Schizophrenia
Voruganti, L., Heslegrave, R. J., & Awad, A. G. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704201008 · Cited by 113
Item response analysis of the Positive and Negative Syndrome Scale
Santor, D. A., Ascher‐Svanum, H., Lindenmayer, J., & Obenchain, R. L. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-66 · Cited by 107
The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.
Heslegrave, R. J., Awad, A. G., & Voruganti, L. N. P. (1997) · PubMed Central · Cited by 106
Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia
Sepehry, A. A., Potvin, S., Elie, R., & Stip, É. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0417 · Cited by 106
Altered Hemispheric Functional Dominance During Word Generation in Negative Schizophrenia
Eric Artiges, A., Martinot, J., Verdys, M., Attar-Levy, D., Mazoyer, B. M., Tzourio‐Mazoyer, N., Giraud, M.-J., & Martinot, M. P. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033488 · Cited by 105
Childhood Trauma and Hippocampal and Amygdalar Volumes in First-Episode Psychosis
Hoy, K., Barrett, S., Shannon, C., Campbell, C., Watson, D., Rushe, T., Shevlin, M., Bai, F., Cooper, S., & Mulholland, C. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr085 · Cited by 103
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial
Potkin, S. G., Alphs, L. D., Hsu, C., Krishnan, K., Anand, R., Young, F. K., Meltzer, H. Y., & Green, A. I. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00178-1 · Cited by 105
Applying Concepts of Generalizability Theory on Clinical Trial Data to Investigate Sources of Variation and Their Impact on Reliability
Vangeneugden, T., Laenen, A., Geys, H., Renard, D., & Molenberghs, G. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.031040.x · Cited by 104
Static and Dynamic Characteristics of Cerebral Blood Flow During the Resting State in Schizophrenia
Kindler, J., Jann, K., Homan, P., Hauf, M., Walther, S., Strik, W. K., Dierks, T., & Hubl, D. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt180 · Cited by 105
Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia
Majadas, S., Olivares, J. M., Galan, J., & Díez, T. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.03.009 · Cited by 104
High resolution examination of the role of sleep disturbance in predicting functioning and psychotic symptoms in schizophrenia: A novel experience sampling study
Mulligan, L. D., Haddock, G., Emsley, R., Neil, S. T., & Kyle, S. D. (2016) · Journal of Abnormal Psychology · doi:10.1037/abn0000180 · Cited by 101
Shared decision-making interventions for people with mental health conditions
Aoki, Y., Yaju, Y., Utsumi, T., Sanyaolu, L. N., Storm, M., Takaesu, Y., Watanabe, K., Watanabe, N., Duncan, E., & Edwards, A. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007297.pub3 · Cited by 114
The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial
Fleischhacker, W. W., Keet, I. P. M., & Kahn, R. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.004 · Cited by 100
Assessing cognitive representations of mental health problems. I. The illness perception questionnaire for schizophrenia
Lobban, F. A., Barrowclough, C., & Jones, S. H. (2005) · British Journal of Clinical Psychology · doi:10.1348/014466504x19497 · Cited by 101

Authors: Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Opler, Lewis A.
Lindenmayer, Jean-Pierre
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 1988-01
Volume: 23
Issue: 1
Pages: 99-110
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/0165-1781(88)90038-8
OpenAlex: W2100828552
Cited by: 1,007
References: 28
Citations by year: 2026: 16 · 2025: 30 · 2024: 38 · 2023: 28 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 37 · 2018: 41 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 37 · 2013: 40 · 2012: 44
FWCI: 8.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: PANSS, schizophrenia, psychometric properties, inter-rater reliability, criterion validity, construct validity, positive symptoms, negative symptoms, cross-validation
MeSH terms: Adult, Female, Humans, Male, Prognosis, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks